A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
VSee Health, Inc. provides telehealth care solutions in the United States. The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions. It also provides telehealth software building blocks, such as patient engagement, clinician staffing, remote physical exam and remote patient monitoring, and AI for telesitter and telenursing solutions; data connectors; and workflow templates. The company distributes its products through third-party resellers and affiliated hospitals, as well as sales executives. The company is headquartered in Newton, Massachusetts.
Financial Summary
| Share Statistics | VSEE | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $3.8 | $179.6 | 3% |
|
| Shares Out (Mil) | 47.9 | 47.9 | 47% |
|
| Institutional Ownership | 28.5% | 78.6% | 13% |
|
| Float (Mil) | 37.7 | 40.1 | 41% |
|
| Beta | 0.49 | 1.22 | 27% |
|
| Avg Daily Volume (000s) | 26,089 | 205 | 99% |
|
| Price Change (52-week) |
(94.0%) | 41.0% | 3% |
|
| Growth | VSEE | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 16.5% | 13.7% | 76% |
|
| Net Income (5yr) | (119.5%) | (1.0%) | 1% |
|
| EPS (5yr) | (97.5%) | 15.5% | 1 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 29.0% | (15.5%) | 85% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | VSEE | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $15 | $192 | 11% |
|
| Net Income (TTM) (Mil) | ($13) | ($9) | 27% |
|
| EPS (TTM) | ($0.476) | ($0.500) | 28% |
|
| Operating Cash Flow (TTM) (Mil) | ($6) | $8 | 24% |
|
| Net Cash Flow (TTM) (Mil) | $1 | ($3) | 47% |
|
| Long-Term Debt (Q1) (Mil) | $1 | $14 | 16% |
|
| Enterprise Value (Q1) (Mil) | $6 | $215 | 6% |
|
| Valuation | VSEE | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.61 | 1.22 | 11% |
|
| P/E | na | 36.1 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 2.0 | na |
|
| Ratios | VSEE | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 46.3% | 61.6% | 58% |
|
| Net Margin | (92.4%) | (29.3%) | 8% |
|
| ROA | (69.5%) | (21.9%) | 8% |
|
| ROE | (945.7%) | (1.4%) | 0% |
|
| Liabilities to Assets | 66.8% | 33.3% | 62% |
|
| F-Score | 4 | 4 | 34% |
|
VSee Health, Inc. did not pass any screens on 7/31/2026.
